By Regulatory Approvals — FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair News-Medical
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 9, 2026.